Acute Kawasaki Disease: Not just for kids

Journal of General Internal Medicine

Volumn 22, Issue 5, 2007, Pages 681-684

  Wolff, Anne E ^a   Hansen, Karen E ^b   Zakowski, Laura ^c  

^a SAINT LOUIS UNIVERSITY   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Adenopathy; Adult; Arthritis; Coronary artery aneurysms; Kawasaki Disease; Mucocutaneous lymph node syndrome; Vasculitis

Indexed keywords

ACETYLSALICYLIC ACID; IMMUNOGLOBULIN;

ACUTE DISEASE; ADULT; ARTHRITIS; ARTICLE; CASE REPORT; CERVICAL LYMPHADENOPATHY; COMPUTER ASSISTED TOMOGRAPHY; CONJUNCTIVITIS; CORONARY ARTERY ANEURYSM; DRUG MEGADOSE; FEVER; HEPATITIS; HUMAN; MALE; MOUTH ULCER; MUCOCUTANEOUS LYMPH NODE SYNDROME; MUCOSA; PHARYNX DISEASE; PHYSICAL EXAMINATION; POLYMORPHONUCLEAR CELL; PULSE RATE; RASH; SKIN EXFOLIATION; SYNOVIAL FLUID; SYSTOLIC HEART MURMUR; TONGUE DISEASE; TREATMENT OUTCOME; WEIGHT REDUCTION; PATHOPHYSIOLOGY; REVIEW;

ACUTE DISEASE; ADULT; ASPIRIN; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME;

EID: 34250376056     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-006-0100-5     Document Type: Article

References (25)

1. Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki Disease. Circulation. 2004;2747-71.
2. Sève P, Stankovic K, Smail A, Durand DV, Marchand G, Broussolle C. Adult Kawasaki Disease: report of two cases and literature review. Semin Arthritis Rheum. 2005;34:785-92.
3. Yanagawa H, Nakamura Y, Yashiro M, et al. Incidence survey of Kawasaki Disease in 1997 and 1998 in Japan. Pediatrics. 2005;107:1-4.
4. Dillon MJ. Childhood vasculitis. Lupus. 1998;7:259-65.
5. Burns JC, Cayan DR, Tong G, et al. Seasonality and temporal clustering of Kawasaki Syndrome. Epidemiology. 2005;16:220-5.
6. Leung DY, Schlievert PM, Meissner HC. The immunopathogenesis and management of Kawasaki Syndrome. Arthritis Rheum. 1998;41:1538-47.
7. Long S. Principles and Practice of Pediatric Infectious Diseases 2nd edition: Chapter 14-Mucocutaneous Symptom Complexes. New York: Churchill Livingstone; 2003:103-8.
8. Falcini F, Trapani S, Turchini S, et al. Immunological findings in Kawasaki Disease: an evaluation in a cohort of Italian children. Clin Exp Rheumatol. 1997;15:685-9.
9. Rider LG, Wener MH, French J, Sherry DD, Mendelman PM. Autoantibody production in Kawasaki syndrome. Clin Exp Rheumatol. 1993;11:445-9.
10. Tomiyama J, Hasegawa Y, Kumagai Y, Adachi Y, Karasawa K. Acute febrile mucocutaneous lynph node syndrome (Kawasaki disease) in adults: case report and review of the literature. Jpn J Med. 1991;30:285-9.
11. Hansen KE, Arnason J, Bridges A. Autoantibodies and common viral illnesses. Semin Arthritis Rheum. 1998;27:263-71.
12. Leung DY, Giorno RC, Kazemi LV, Flynn PA, Busse JB. Evidence for superantigen involvement in cardiovascular injury due to Kawasaki Syndrome. J Immunol. 1995;155:5018-21.
13. Rauch AM, Glode MP, Wiggins JW, et al. Outbreak of Kawasaki Syndrome in Denver, Colorado: association with rug and carpet cleaning. Pediatrics. 1991;87:663-9.
14. Jackson JL, Kunkel MR, Libow L, Gates RH. Adult Kawasaki Disease: report of two cases treated with intravenous gamma globulin. Arch Intern Med. 1994;154:1398-405.
15. Rozo JC, Jefferies JL, Eidem BW, Cook PJ. Kawasaki Disease in the adult: a case report and review of the literature. Texas Heart Inst J. 2004;31:160-4.
16. Newburger JW, Takahashi M, Burns JC, et al. The treatment of Kawasaki Syndrome with intravenous gamma globulin. New Engl J Med. 1986;315:341-7.
17. Koren G, Rose V, Lavi S, Rowe R. Probable efficacy of high-dose salicylates in reducing coronary involvement in Kawasaki Disease. 1985;254:767-9.
18. Furusho K, Nakano H, Shinomiya K, et al. High dose intravenous gamma globulin for Kawasaki Disease. Lancet. 1984;2:1055-8.
19. Newburger JW, Takahasi M, Beiser AS, et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki Syndrome. New Engl J Med. 1991;324:1633-9.
20. Oates-Whitehead RM, Baumer JH, Haines L, et al. Intravenous immunoglobulin for the treatment of Kawasaki disease in children. Cochrane Database Syst Rev 2003;(4):CD004000.
21. Bayrou O, Phlippoteau C, Artigou C, Haddad T, Leynadier F. Adult Kawasaki syndrome associated with HIV infection and anti-cardiolipin antibodies. J Am Acad Dermatol. 1993;29:663-4.
22. Fason JT, Fry YW, Smith D. Kawasaki Disease in a postpartum patient. J Natl Med Assoc. 2004;96:1499-1502.
23. Kato H, Koike S, Yokoyama T. Kawasaki Disease: effect of treatment on coronary artery involvement. Pediatrics. 1979;63:175-9.
24. Sundel RP, Baker AL, Fulton DR, Newburger JW. Corticosteroids in the initial treatment of Kawasaki disease: report of a randomized trial. J Pediatr. 2003;142:611-6.
25. Wooditch AC, Aronoff SC. Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: a meta-analysis of 862 children. Pediatrics. 2005;116:989.